Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Here We Go Again: The Medicare Advantage Open Enrollment Period
The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...
Medscape1h
How Long Does It Take to See a Neurologist?
On average, older adults waited 34 days for a new visit to a neurologist after a referral, and nearly 20% waited more than 3 ...
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...
Drugs not selected for Medicare negotiations saw prices nearly double - report
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
Mastering Medicare Appeals: Your Guide to Overturning Denials
On the other hand, Medicare Advantage plans have a more nuanced process. These plans require prior approval for all claims, making the insurance carrier the first point of contact for denials. While ...
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
BioSpace23h
Lilly Wins Medicare Coverage for Zepbound in Sleep Apnea
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
Watch Out for the ‘Medigap Trap’
The Medigap trap can snag those who chose Medicare Advantage and plan to switch to traditional Medicare later as their needs ...